| Literature DB >> 25539682 |
Kate J Howell1, Lucy A Weinert2, Roy R Chaudhuri3, Shi-Lu Luan4, Sarah E Peters5, Jukka Corander6, David Harris7, Øystein Angen8, Virginia Aragon9, Albert Bensaid10, Susanna M Williamson11, Julian Parkhill12, Paul R Langford13, Andrew N Rycroft14, Brendan W Wren15, Matthew T G Holden16, Alexander W Tucker17, Duncan J Maskell18.
Abstract
BACKGROUND: Haemophilus parasuis is the etiologic agent of Glässer's disease in pigs and causes devastating losses to the farming industry. Whilst some hyper-virulent isolates have been described, the relationship between genetics and disease outcome has been only partially established. In particular, there is weak correlation between serovar and disease phenotype. We sequenced the genomes of 212 isolates of H. parasuis and have used this to describe the pan-genome and to correlate this with clinical and carrier status, as well as with serotype.Entities:
Mesh:
Year: 2014 PMID: 25539682 PMCID: PMC4532294 DOI: 10.1186/1471-2164-15-1179
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1isolate collection displayed by serovar and disease. Each serovar includes those found with cross-reactions. NT denotes 'non-typeable’ by serotyping either due to no reaction or due to more than three reactions to the serotyping antisera. Strains without serotyping data are excluded.
Figure 2Core genome Neighbor-joining tree (with areas of recombination included) of (500 bootstraps). Trees are overlaid with the populations from the Bayesian analysis of population structure (BAPS), which represent isolates with similar rates of homologous recombination. Further metadata including disease association, serovar and country of origin are also shown. BAPS populations explain the separation of the isolates on the tree into two main clades.
Figure 3The BAPS populations defined using Bayesian analysis of population structure represent isolates with similar rates of homologous recombination. The BAPS populations have been compared to serovar, disease association and country of origin. Some similarity in the BAPS populations 3 and 5 can be seen based on serovar distribution. Very little difference can be seen between BAPS population when disease association is considered. UK isolates are overrepresented in BAPS populations 1, 3 and 4, while 2 and 5 are of mixed geographic origin.
Figure 4Heat-map of the shared accessory genes between strains. The plot is ordered by the phylogeny based on the SNPs within the core genome (rows). While the columns are ordered based on the similarity in the presence and absence pattern of accessory genes between isolates, which is represented by a dendrogram along the top of the heat-map. A clear separation can be seen between the clades, and it appears that both the phylogeny and the dendrogram split the population into the two clades, suggesting little recombination occurs between the two clades, but there is recombination within them both.
Figure 5Discriminant analysis of principal components applied to clinical strains of by disease categories. 80% eigenvalues were retained for the PCA and all eigenvalues were retained for the discriminant analysis. Plots a and b show the first axis of the discriminant function while c, d, e and f show the first two axes. Separation along the axes suggests that genetic differences are present between the phenotypic groups of clinical and non-clinical isolates that are being compared; however the presence of overlap shows that some strains are intermediates. Plots c and d show that geographic origin, do not show much separation of the isolates by geography, those that have separated are only represented by a couple of isolates. On the other hand, the discriminant function based on the BAPS populations shows a lot of separation and so the population structure does have an influence on these isolates genetic content.
Significantly different genes identified from H. parasuis between clinical and non-clinical isolates using DAPC
| Predicted function of gene | Number of genes | Existing virulence factor for
|
|---|---|---|
| Adhesins, | 4 | Yes |
| antirepressor | 1 | |
| Aspartokinase | 1 | |
| ATPdependent RNA helicase | 1 | |
| cytolethal distending toxin protein A | 2 | Yes |
| cytolethal distending toxin protein B | 1 | Yes |
| DNA binding domain, excisionase family | 1 | |
| enoyl-CoA hydratase/carnithine racemase-like protein | 1 | |
| Ferric hydroxamate uptake | 1 | |
| Gene 25like lysozyme | 1 | |
| glycerol uptake facilitator protein | 1 | |
| Modification methylase | 1 | |
| MuF Haemophilus phage SuMu | 1 | |
| N-acetylmuramoyl-L-alanine amidase | 1 | |
| phage tail sheath family protein | 1 | |
| putative 3-phenylpropionic acid transporter | 1 | |
| Putative NADH flavin reductase/short chain dehydrogenase | 1 | |
| putative outer membrane usher protein | 1 | |
| putative serine protease | 1 | Yes |
| tonB-dependent receptor plug domain protein | 1 | Yes |
| Trans-2,3-dihydro-3-hydroxyanthranilate isomerase | 1 | |
| Transcriptional activator | 1 | |
| transposase | 1 | |
| UDP3O [3hydroxymyristoyl] glucosamine N-acyltransferase | 1 | |
| unknown function | 19 | |
| Xylose import ATPbinding protein | 1 |
All genes were identified as significant using generalised linear modelling of different DAPC iterations using between 60-90% of the principal components (p < 0.05). The phenotypic data used in the model was whether isolates were clinical or non-clinical compared to the presence or absence of the genes.